ZNF43
gene geneOn this page
Also known as HTF6KOX27
Summary
ZNF43 (zinc finger protein 43, HGNC:13109) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 43 (P17038). May be involved in transcriptional regulation.
This gene belongs to the C2H2-type zinc finger gene family. The zinc finger proteins are involved in gene regulation and development, and are quite conserved throughout evolution. Like this gene product, a third of the zinc finger proteins containing C2H2 fingers also contain the KRAB domain, which has been found to be involved in protein-protein interactions.
Source: NCBI Gene 7594 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 25 total
- MANE Select transcript:
NM_003423
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13109 |
| Approved symbol | ZNF43 |
| Name | zinc finger protein 43 |
| Location | 19p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HTF6, KOX27 |
| Ensembl gene | ENSG00000198521 |
| Ensembl biotype | protein_coding |
| OMIM | 603972 |
| Entrez | 7594 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 10 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000354959, ENST00000357491, ENST00000593551, ENST00000593886, ENST00000594012, ENST00000594312, ENST00000595461, ENST00000596899, ENST00000598288, ENST00000598381, ENST00000599414, ENST00000599906, ENST00000942356
RefSeq mRNA: 7 — MANE Select: NM_003423
NM_001256648, NM_001256649, NM_001256650, NM_001256651, NM_001256653, NM_001256654, NM_003423
CCDS: CCDS12413, CCDS59367, CCDS74321
Canonical transcript exons
ENST00000354959 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001418042 | 21804946 | 21809807 |
| ENSE00003159524 | 21836036 | 21836182 |
| ENSE00003494333 | 21817888 | 21817986 |
| ENSE00003668336 | 21819095 | 21819221 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 89.83.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.4070 / max 491.2396, expressed in 1592 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180243 | 6.1565 | 1181 |
| 180237 | 5.9201 | 1384 |
| 180236 | 2.2064 | 925 |
| 180238 | 0.5093 | 235 |
| 180242 | 0.4685 | 281 |
| 180241 | 0.1462 | 53 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 89.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 89.70 | gold quality |
| ventricular zone | UBERON:0003053 | 89.03 | gold quality |
| corpus callosum | UBERON:0002336 | 88.84 | gold quality |
| adrenal tissue | UBERON:0018303 | 86.28 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.89 | gold quality |
| bone marrow cell | CL:0002092 | 85.34 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.20 | gold quality |
| endometrium | UBERON:0001295 | 84.02 | gold quality |
| bone marrow | UBERON:0002371 | 83.55 | gold quality |
| colonic epithelium | UBERON:0000397 | 82.97 | gold quality |
| cortical plate | UBERON:0005343 | 81.46 | gold quality |
| tonsil | UBERON:0002372 | 80.84 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.53 | gold quality |
| lymph node | UBERON:0000029 | 79.66 | gold quality |
| sural nerve | UBERON:0015488 | 78.99 | gold quality |
| cortex of kidney | UBERON:0001225 | 78.85 | gold quality |
| rectum | UBERON:0001052 | 78.43 | gold quality |
| testis | UBERON:0000473 | 78.09 | gold quality |
| right testis | UBERON:0004534 | 77.82 | gold quality |
| kidney | UBERON:0002113 | 77.44 | gold quality |
| left testis | UBERON:0004533 | 77.19 | gold quality |
| spleen | UBERON:0002106 | 77.10 | gold quality |
| ovary | UBERON:0000992 | 76.91 | gold quality |
| apex of heart | UBERON:0002098 | 76.79 | gold quality |
| prostate gland | UBERON:0002367 | 76.50 | gold quality |
| fallopian tube | UBERON:0003889 | 76.49 | gold quality |
| metanephros cortex | UBERON:0010533 | 76.41 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 76.39 | gold quality |
| urinary bladder | UBERON:0001255 | 76.39 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.88 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2564.1 | ZNF43 | More than 3 adjacent zinc fingers |
| MA2692.1 | ZNF43 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
Upstream regulators (CollecTRI, top): E2F6
miRNA regulators (miRDB)
113 targeting ZNF43, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
Literature-anchored findings (GeneRIF, showing 1)
- Human embryo kidney cells that overexpressed AAK1 are adriamycin resistant (PMID:17178891)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 43 — P17038 (reviewed: P17038)
Alternative names: Zinc finger protein 39, Zinc finger protein HTF6, Zinc finger protein KOX27
All UniProt accessions (6): A0A087WSW2, P17038, M0QXI2, M0QYJ6, M0R0T7, M0R3D5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. T- and B-cell lines.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P17038-1 | 1 | yes |
| P17038-2 | 2 |
RefSeq proteins (7): NP_001243577, NP_001243578, NP_001243579, NP_001243580, NP_001243582, NP_001243583, NP_003414* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352, PF13912
UniProt features (33 total): zinc finger region 22, sequence conflict 6, sequence variant 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17038-F1 | 72.22 | 0.04 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 105 (showing top):
PUJANA_CHEK2_PCC_NETWORK, MODULE_205, BLALOCK_ALZHEIMERS_DISEASE_UP, chr19p12, MODULE_123, SCHLOSSER_SERUM_RESPONSE_DN, MODULE_98, BECKER_TAMOXIFEN_RESISTANCE_DN, MODULE_198, STEIN_ESRRA_TARGETS_UP, MALONEY_RESPONSE_TO_17AAG_DN, PUJANA_XPRSS_INT_NETWORK, HAMAI_APOPTOSIS_VIA_TRAIL_UP, GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
396 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF43 | CTSF | Q9UBX1 | 418 |
| ZNF43 | CXADR | P78310 | 400 |
| ZNF43 | LCP1 | P13796 | 398 |
| ZNF43 | TACSTD2 | P09758 | 395 |
| ZNF43 | CEACAM6 | P40199 | 389 |
| ZNF43 | BST2 | Q10589 | 371 |
| ZNF43 | POLR2F | P41584 | 368 |
| ZNF43 | Q6GMV1 | Q6GMV1 | 358 |
| ZNF43 | KRABD2 | Q6ZNG9 | 356 |
| ZNF43 | IDO1 | P14902 | 353 |
| ZNF43 | CTRB1 | P17538 | 347 |
| ZNF43 | C12orf42 | Q96LP6 | 337 |
| ZNF43 | ZNG1F | Q4V339 | 314 |
| ZNF43 | ZNG1C | Q5JTY5 | 313 |
| ZNF43 | ZNF92 | Q03936 | 309 |
IntAct
0 interactions, top by confidence:
BioGRID (4): ZNF43 (Affinity Capture-MS), ZNF43 (Co-fractionation), ZNF43 (Cross-Linking-MS (XL-MS)), ZNF43 (Affinity Capture-RNA)
ESM2 similar proteins: A2VDQ7, A6NK75, A6NN14, A6NNF4, A8MQ14, A8MTY0, A8MXY4, B7Z6K7, E9QAG8, O43345, O75290, O75373, O75437, P0CJ79, P10751, P17017, P17019, P17035, P17038, P18749, P35789, P51522, Q03923, Q03938, Q05481, Q14585, Q3SYV7, Q4V348, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6P5C7, Q6ZN08, Q6ZN57, Q6ZR52, Q86V71, Q86XN6, Q8IYB9, Q8N7Q3
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
5413 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:21807892:A:C | F715L | 0.991 |
| 19:21807892:A:T | F715L | 0.991 |
| 19:21807894:A:G | F715L | 0.991 |
| 19:21807976:A:C | F687L | 0.991 |
| 19:21807976:A:T | F687L | 0.991 |
| 19:21807978:A:G | F687L | 0.991 |
| 19:21807887:C:G | R717P | 0.988 |
| 19:21808564:A:C | F491L | 0.988 |
| 19:21808564:A:T | F491L | 0.988 |
| 19:21808566:A:G | F491L | 0.988 |
| 19:21807808:A:C | F743L | 0.987 |
| 19:21807808:A:T | F743L | 0.987 |
| 19:21807810:A:G | F743L | 0.987 |
| 19:21808312:A:C | F575L | 0.985 |
| 19:21808312:A:T | F575L | 0.985 |
| 19:21808314:A:G | F575L | 0.985 |
| 19:21807724:G:C | F771L | 0.982 |
| 19:21807724:G:T | F771L | 0.982 |
| 19:21807726:A:G | F771L | 0.982 |
| 19:21808060:A:C | F659L | 0.982 |
| 19:21808060:A:T | F659L | 0.982 |
| 19:21808062:A:G | F659L | 0.982 |
| 19:21808396:A:C | F547L | 0.981 |
| 19:21808396:A:T | F547L | 0.981 |
| 19:21808398:A:G | F547L | 0.981 |
| 19:21807875:A:G | L721P | 0.979 |
| 19:21808228:A:C | F603L | 0.978 |
| 19:21808228:A:T | F603L | 0.978 |
| 19:21808230:A:G | F603L | 0.978 |
| 19:21808648:A:C | F463L | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000014656 (19:21847163 C>G), RS1000042857 (19:21812992 T>C), RS1000048760 (19:21835336 T>A), RS1000138487 (19:21852438 T>C,G), RS1000147511 (19:21831244 T>C), RS1000153979 (19:21846879 T>C), RS1000155814 (19:21820282 T>A), RS1000216861 (19:21807121 G>A,T), RS1000236761 (19:21848487 G>A), RS1000268029 (19:21820584 AAAAAG>A), RS1000270525 (19:21847080 C>T), RS1000406173 (19:21842641 T>C), RS1000410562 (19:21813264 A>G,T), RS1000437453 (19:21842357 T>A), RS1000447829 (19:21852151 G>A)
Disease associations
OMIM: gene MIM:603972 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 5 |
| trichostatin A | decreases expression, affects cotreatment | 2 |
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| methylselenic acid | decreases expression | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| cobaltous chloride | increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| nickel sulfate | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Vanadates | decreases expression | 1 |
| Isotretinoin | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.